HBIO
HARVARD BIOSCIENCE INC
HARVARD BIOSCIENCE INC (HBIO) has 7 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 12, 2026.
- Industry:Medical - Instruments & Supplies
- CEO:John Duke
- Employees:330
- HQ:Holliston, MA, US
- IPO:2001-03-19
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$27.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Frost Mark TFirst filing | Chief Financial Officer | Purchase | 5,000 | $25K | Apr 1 | SEC ↗ |
Related companies
HARVARD BIOSCIENCE INC is in the Healthcare sector.